AMENDMENT TO AGREEMENTAmendment to Agreement • May 21st, 2018 • Broadfin Capital, LLC • Pharmaceutical preparations
Contract Type FiledMay 21st, 2018 Company IndustryThis amendment to agreement (this “Amendment ”) is made and entered into as of May 20, 2018, by and between BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and Broadfin Healthcare Master Fund, Ltd., a Cayman Islands exempted company (“Broadfin Healthcare”), and its affiliates (such Affiliates (as defined herein) together with Broadfin Healthcare, “Broadfin”). Each of the Company and Broadfin is referred to herein as a “Party” and, collectively, as the “Parties”.
AMENDMENT TO AGREEMENTAmendment to Agreement • May 21st, 2018 • Biodelivery Sciences International Inc • Pharmaceutical preparations
Contract Type FiledMay 21st, 2018 Company IndustryThis amendment to agreement (this “Amendment ”) is made and entered into as of May 20, 2018, by and between BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and Broadfin Healthcare Master Fund, Ltd., a Cayman Islands exempted company (“Broadfin Healthcare”), and its affiliates (such Affiliates (as defined herein) together with Broadfin Healthcare, “Broadfin”). Each of the Company and Broadfin is referred to herein as a “Party” and, collectively, as the “Parties”.